Skip to content

Acquisitions at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
$202.2M+278%
IQVIA logo
IQVIAIQV
$37M-72.4%
Agilent Technologies logo
Agilent TechnologiesA
$0
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$8.87B
Quest Diagnostics logo
Quest DiagnosticsDGX
$38M
WAT
Waters CorporationWAT
$144M

Other financials

Income statement

See full
Revenue$995.8M+1.2%
Gross profit$349.0M-3.5%
Operating income$119.9M+60.6%
Net income-$14.8M-158%
EPS (diluted)-$0.30-160%

Balance sheet

See full
Cash & equivalents$198.2M-14.5%
Total debt$3.1B+1.9%
Total equity$2.9B-7.9%
Total assets$7.7B+2.0%

Cash flow

See full
Operating cash flow$41.1M-76.1%
CapEx$55.9M-5.8%
Free cash flow-$14.8M-113%

Valuation

See full
Market cap$8.91B+10.3%
Enterprise value$11.79B+8.5%
P/S2.2×+0.2×

Profitability

See full
Gross margin84.7%
Operating margin13%-2.4pp
Net margin-4.6%
FCF margin9.7%-4.3pp

Returns & leverage

See full
Return on equity-6%
Debt / equity+0.1×
Current ratio1.4×-0.1×

Where this comes from

Reported directly by Charles River Laboratories in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired.

The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Charles River Laboratories's acquisitions.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Charles River Laboratories's acquisitions?
Charles River Laboratories (CRL) reported acquisitions of $405.01M in Q1 2026.
What does acquisitions mean?
Cash paid to purchase other companies or business units.
How do you interpret acquisitions?
Large outflows indicate aggressive growth strategies; consistent acquisitions may signal a reliance on inorganic growth.
How does acquisitions compare across companies?
Commonly used to benchmark growth strategies against industry peers who also pursue M&A.